Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Kjartan Moe"'
Autor:
Daniel Pitz Jacobsen, Heidi Elisabeth Fjeldstad, Guro Mørk Johnsen, Ingrid Knutsdotter Fosheim, Kjartan Moe, Patji Alnæs-Katjavivi, Ralf Dechend, Meryam Sugulle, Anne Cathrine Staff
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Decidua basalis, the endometrium of pregnancy, is an important interface between maternal and fetal tissues, made up of both maternal and fetal cells. Acute atherosis is a uteroplacental spiral artery lesion. These patchy arterial wall lesions contai
Externí odkaz:
https://doaj.org/article/0bd63ea6bcf54a9784a9e676a2920e0c
Autor:
Daniel P. Jacobsen, Ragnhild Røysland, Heidi Strand, Kjartan Moe, Meryam Sugulle, Torbjørn Omland, Anne Cathrine Staff
Publikováno v:
Acta Diabetologica. 59:1229-1236
Aim Cardiovascular disease (CVD) is a leading cause of death in both men and women. Type 1 and 2 diabetes mellitus (DM1 and DM2) are well-known risk factors for CVD. In addition, gestational diabetes mellitus (GDM) is a female sex-specific risk facto
Autor:
Ingrid Knutsdotter Fosheim, Meryam Sugulle, Kjartan Moe, Heidi Elisabeth Fjeldstad, Patji Alnæs-Katjavivi, Gitta Turowski, Guro Mørk Johnsen, Anne Cathrine Staff
Publikováno v:
American Journal of Obstetrics and Gynecology. 226:S895-S906
Physiological transformation with remodeling of the uteroplacental spiral arteries is key to a successful placentation and normal placental function. It is an intricate process that involves, but is not restricted to, complex interactions between mat
Publikováno v:
Pregnancy Hypertension. 21:23-29
Objectives Women with a previous hypertensive disorder of pregnancy (HDP: gestational hypertension and preeclampsia) have increased long-term cardiovascular disease risk. Recent meta-analyses show adverse levels of non-invasive functional and structu
Autor:
Daniel P. Jacobsen, Ragnhild Røysland, Heidi Strand, Kjartan Moe, Meryam Sugulle, Torbjørn Omland, Anne Cathrine Staff
Cardiovascular disease (CVD) is the leading cause of death in women, yet sex-specific risk factors remain understudied. Preeclampsia and other adverse pregnancy outcomes imply an increased maternal cardiovascular risk. We hypothesized that cardiac tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb510d6c5f04da1f91f68884fdd3910
http://hdl.handle.net/10852/98679
http://hdl.handle.net/10852/98679
Publikováno v:
Eur J Prev Cardiol
Background Previous preeclampsia, gestational hypertension and gestational diabetes mellitus show a firm epidemiological association to maternal cardiovascular disease risk. Cardiovascular disease risk assessment is recommended in women after these p
Autor:
Goran Petrovski, Kjartan Moe, Sissel Hoel, Anne Cathrine Staff, Meryam Sugulle, Nina C.B.B. Veiby
Publikováno v:
Pregnancy Hypertension. 25:e61-e62
Publikováno v:
Pregnancy hypertension. 25
Objectives Women with previous preeclampsia (PE), gestational hypertension (GH), or gestational diabetes mellitus (GDM) have increased cardiovascular disease (CVD) risk. Physical activity (PA) is an important CVD risk modifier. We aimed to assess PA
Multiplex Analysis of Circulating Maternal Cardiovascular Biomarkers Comparing Preeclampsia Subtypes
Autor:
Meryam Sugulle, Christopher W.G. Redman, Ralf Dechend, Tove Lekva, Anne Cathrine Staff, Kjartan Moe
Preeclampsia, a hypertensive pregnancy disorder, links to increased long-term maternal cardiovascular disease (CVD). The risk is further increased with early-onset preeclampsia (EPE) and delivery of a growth-restricted child. We hypothesized that cir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::456cc337bb53a0048d93b36f0602fc63
http://hdl.handle.net/10852/84745
http://hdl.handle.net/10852/84745
Autor:
Heidi E.S. Fjeldstad, Tove Lekva, Ralf Dechend, Daniel P. Jacobsen, Anne Cathrine Staff, Meryam Sugulle, Kjartan Moe
Publikováno v:
Journal of Reproductive Immunology. 146:103331
Human Leukocyte Antigen-G (HLA-G) prevents the activity of immune cells and is decreased in women with preeclampsia. We aimed to investigate the associations between circulating soluble HLA-G (sHLA-G) and 92 cardiovascular disease-related biomarkers